Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Financial Comparison: GE HealthCare Technologies (NASDAQ:GEHC) and Insulet (NASDAQ:PODD)
02:32am, Friday, 20'th Feb 2026
Insulet (NASDAQ: PODD - Get Free Report) and GE HealthCare Technologies (NASDAQ: GEHC - Get Free Report) are both large-cap medical companies, but which is the better stock? We will contrast the two c
Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations
12:20pm, Thursday, 19'th Feb 2026
Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations
PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise
09:10am, Thursday, 19'th Feb 2026
Insulet jumps after Q4 EPS and revenue beat, margin expansion and record Omnipod growth power a strong 2025 finish and upbeat 2026 outlook.
Insulet (NASDAQ:PODD) Shares Gap Up on Earnings Beat
01:59am, Thursday, 19'th Feb 2026
Insulet Corporation (NASDAQ: PODD - Get Free Report) gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $246.34,
Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript
04:54pm, Wednesday, 18'th Feb 2026
Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript
Insulet Corp (PODD) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Innovations
02:00pm, Wednesday, 18'th Feb 2026
Total Revenue: $784 million in Q4 2025, a 29% increase in constant currency.Full Year Revenue: Surpassed $2.7 billion, with approximately 30% year-over-year co
Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars
01:57pm, Wednesday, 18'th Feb 2026
Insulet Corporation (NASDAQ: PODD) stock is trading higher on Wednesday after the company reported better-than-expected fourth-quarter earnings and 2026 guidance.
Insulet (PODD) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Wednesday, 18'th Feb 2026
The headline numbers for Insulet (PODD) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Insulet (PODD) Tops Q4 Earnings and Revenue Estimates
09:15am, Wednesday, 18'th Feb 2026
Insulet (PODD) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.15 per share a year ago.
Insulet beats quarterly estimates on strong demand for wearable insulin pumps
07:55am, Wednesday, 18'th Feb 2026
Insulet reported better-than-expected fourth-quarter results on Wednesday, on the back of strong demand for its tubeless insulin pumps that eliminate the need for daily injections.
Insulet Reports Fourth Quarter and Full Year 2025 Results
07:00am, Wednesday, 18'th Feb 2026
ACTON, Mass.--(BUSINESS WIRE)--Insulet Reports Fourth Quarter and Full Year 2025 Results.
Aberdeen Group plc Has $47.80 Million Stock Holdings in Insulet Corporation $PODD
03:16am, Monday, 16'th Feb 2026
Aberdeen Group plc raised its position in Insulet Corporation (NASDAQ: PODD) by 8.1% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 154,822 shares of th
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market
11:26am, Friday, 13'th Feb 2026
/PRNewswire/ -- Equity-Insider.com News Commentary - The global health and wellness sector is entering 2026 on a trajectory toward $6 trillion in annual
Exploring Analyst Estimates for Insulet (PODD) Q4 Earnings, Beyond Revenue and EPS
10:15am, Thursday, 12'th Feb 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Insulet (PODD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth
11:01am, Wednesday, 11'th Feb 2026
Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
